Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-24-000844
Filing Date
2024-07-03
Accepted
2024-07-03 17:01:03
Documents
4
Period of Report
2024-07-03

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 11356
2 PRESS RELEASE, DATED JULY 3, 2024 ex991.htm EX-99.1 16749
3 GRAPHIC logo.jpg GRAPHIC 23734
4 GRAPHIC image_001.jpg GRAPHIC 116717
  Complete submission text file 0001279569-24-000844.txt   222842
Mailing Address 201-2067 CADBORO BAY RD. VICTORIA A1 V8R 5G4
Business Address 201-2067 CADBORO BAY RD. VICTORIA A1 V8R 5G4 250-590-3968
EUPRAXIA PHARMACEUTICALS INC. (Filer) CIK: 0001581178 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41923 | Film No.: 241100812
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)